Exogenous CD19 stimulation in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy, sequential rapid immune-assay in heparin-induced thrombocytopenia diagnosis, and new survival prediction models for chronic myelomonocytic leukemia
This episode of the Blood Podcast discusses exogenous CD19 stimulation in CAR T-cell therapy for B-cell ALL, new sequential rapid immune-assays for HIT diagnosis, and resource-adaptive survival prediction models for CMML.